Brand Name : Rdfos Tablets
Composition : Risedronate Sodium Tablets IP 35mg
Packing : 10*4 Tablets
Quick EnquiryComposition : Risedronate Sodium Tablets IP 35mg
Packing : 10*4 Tablets
Quick EnquiryComposition (Each tablet contains):
Risedronate Sodium I.P.
(Equivalent to Risedronate): 35 mg
Excipients: q.s.
Dosage Form: Oral Tablet
Therapeutic Class: Bisphosphonate (For Osteoporosis & Bone Disorders)
Risedronate (Actonel) belongs to the group of drugs known as bisphosphonates and is generally considered to be one of the best drugs for treating osteoporosis, or bone loss and weakening. mg may help increase bone mineral density (BMD) and reduce the risk of bone fractures. There are several dosing options and a delayed-release form in case a particular dosing schedule is more convenient for some people.
Risedronate belongs to a group of medicines called bisphosphonates. The bisphosphonates help to inhibit bone loss that can prevent the body from building new bone, healthy and strong. Risedronate (Actonel) increases BMD, a measure of bone density. The greater the BMD, the stronger your bones will be, reducing your risk of bone fracture.
This is where the majority of patients make a mistake and could directly impact the effectiveness of the medicine. Do the following steps carefully:
In patients suitable for the procedure (based on bone density and fracture risk), the known benefits are:
Decreased risk of vertebral fracture: Clinical trials demonstrated clinically significant relative risk reductions in new spinal fractures as early as after the first year of treatment and compared to a placebo group.
Lower risk of hip fracture for post-menopausal women who have osteoporosis and other risk factors.
Increased bone mineral density after treatment at various sites, including the lumbar spine, femoral neck, hip, and others.
Comparable effectiveness of once a week vs. once a day (the once-weekly dose of 35 mg has been shown to be as effective as the once-daily dose of 5 mg, without the daily hassle).
The following side effects may get better over time as your body gets used to the medication. Contact your health care provider right away if you still have these symptoms or if they get worse over time.
What's the purpose of risedronate sodium 35 mg?
It is a treatment for osteoporosis, namely to reduce the risk of fracture in postmenopausal women and to treat osteoporosis in men at high risk of fracture.
What are the Risedronate Side Effects?
The most frequently reported side effects include headache, constipation, indigestion, nausea, abdominal pain, diarrhea, and musculoskeletal pain. Uncommon, but more serious side effects include atypical femur fractures and osteonecrosis of the jaw that have been associated with long-term use.
What is the best time to take risedronate sodium 35 mg tablets ?
Eating or drinking (except water) or taking any other medicine should be done at least 30 minutes before and after the morning dose, and the person should remain standing for at least 30 minutes following.
What is the advantage of having risedronate sodium 35 mg tablets?
Over time, it improves the likelihood of avoiding vertebral and hip fracture and makes bone mineral density more, particularly within the first year of treatment for proper candidates.
Can you just stop taking risedronate sodium 35 mg tablets?
Treatment should not be stopped prematurely without consulting with the doctor; it should be reviewed every 5 years or so depending on the individual fracture risk and bone density trend.
Can risedronate sodium 35 mg tablets cause hair loss?
Yes, but it is not a common problem. If you experience hair loss while taking risedronate, let your doctor know; don't think it's a coincidence.
Can risedronate sodium 35 mg tablets be used while you're pregnant?
No — because there is an insufficient amount of data showing it to be safe during pregnancy and breastfeeding, and animal studies indicate potential risk. If you become pregnant while taking this drug, let your doctor know right away.
Let’s have a look at the product range available at Human Biolife India for the Monopoly business in India
2026 © Human Biolife India PVT. LTD.